# OnCo record paper-olympia-nejm-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-olympia-nejm-2021" ;
schema:name "OlympiA: a year of olaparib after surgery for BRCA-mutated, high-risk early breast cancer"@en ;
schema:description "In women born with a BRCA1 or BRCA2 mutation whose early breast cancer was high risk, a year of the PARP inhibitor olaparib after standard treatment cut relapses by more than 40% and later improved survival."@en ;
schema:url ;
schema:dateModified "2026-09-08"^^xsd:date ;
schema:citation , ;
schema:sameAs ;
schema:datePublished "2021"^^xsd:gYear ;
schema:author "Tutt ANJ, Garber JE, Kaufman B, et al." ;
onco:cancers , ;
onco:technologies , , ;
onco:targets , ;
onco:drugs ;
onco:companies , ;
onco:terms , , , ;
onco:trials ;
onco:people , , , , , , , ;
onco:bottlenecks , ;
onco:journals .